跳至主要内容
临床试验/DRKS00017020
DRKS00017020招募中未知

earned pharmacological responses on cell proliferation: Inhibiting the mTOR-signaling pathway

niversitätsklinikum Essen0 个研究点目标入组 80 人开始时间: 2019年4月3日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
Male

入选标准

  • Only healthy male non-smokers between the ages of 18 and 40 will be included. Each subject will be given a comprehensive medical examination at the Clinic for Infectious Diseases approximately 1 week before the start of the study (anamnesis interview, internal examination, blood test, ECG). A final examination will be carried out one week after participation in the study.

排除标准

  • The presence of immunological, endocrine, cardiovascular, haematological and psychiatric diseases leads to exclusion from the study. Further exclusion criteria are an increased BMI (>30), allergies e.g. to substances used during the study (lactose intolerance), liver or kidney diseases, obstructive respiratory diseases, addictions or diabetes mellitus.

研究者

发起方
niversitätsklinikum Essen

相似试验

earned pharmacological responses on cell... | 临床试验